Literature DB >> 8235270

[The laparoscopy method in preoperative evaluation of patients with malignant stomach neoplasm].

D R Oliveira1, U Ribeiro Júnior, B Bitelman, M Polak, C Bresciani, J Gama-Rodrigues, A A Laudanna, H W Pinotti.   

Abstract

In 190 patients with malignant gastric neoplasia the value of laparoscopy for diagnosing intra-abdominal metastases was investigated. At the laparoscopic examination the presence of tumoral tissue was appraised on the serosal coat of the stomach, epiploons, parietal and visceral peritoneum, and in the liver. On hand of laparoscopic findings (peritoneal or hepatic metastases) the surgical treatment was discarded in 34 patients (70.6%). In the remaining 29.4% of patients a bad general condition or concomitant diseases contra-indicated surgical intervention. A comparison of laparoscopic and surgical findings showed that correct diagnosis was established by laparoscopy in 61.4% of cases with tumoral invasion of gastric serosa, in 21.4% of cases with involvement of epiploon, in 27% of parietal peritoneum, and in 33.3% of the liver. Falsely positive findings were rare (5% of examinations).

Entities:  

Mesh:

Year:  1993        PMID: 8235270

Source DB:  PubMed          Journal:  Rev Hosp Clin Fac Med Sao Paulo        ISSN: 0041-8781


  2 in total

1.  Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection?

Authors:  Ulysses Ribeiro; Adriana V Safatle-Ribeiro; Bruno Zilberstein; Donato Mucerino; Osmar Kenji Yagi; Cláudio Caldas Bresciani; Carlos Eduardo Jacob; Kyioshi Iryia; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

2.  Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer.

Authors:  U Ribeiro; J J Gama-Rodrigues; A V Safatle-Ribeiro; B Bitelman; R E Ibrahim; M B Ferreira; A A Laudanna; H W Pinotti
Journal:  J Gastrointest Surg       Date:  1998 May-Jun       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.